FWD-14325-20714
3 vaccinations
3 coded responses
42 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 787 / TX
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Pfizer-BioNTech
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-19
- 2021-04-24
- 2021-05-01
-
2021-05-03
Dose 2 — Pfizer-BioNTech
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-06
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-06-14
- 2021-08-02
- 2021-11-01
- 2022-05-03
-
2022-05-16
Dose 3 — Pfizer-BioNTech
-
2022-05-16
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-17
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-05-18
- 2022-05-19
- 2022-05-20
- 2022-05-21
-
2022-05-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-05-23
- 2022-05-30
-
2022-06-06
Survey response — day 21, dose 3MedDRA: Nausea, Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: Increased nausea and vomiting.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-13
-
2022-06-20
Survey response — day 35, dose 3MedDRA: Cough, Respiratory tract congestion, Sneezing — Feeling: FairFree text: Lots of congestion, sneezing, mild cough.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Survey response — day 42, dose 3MedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Mild fever, bad cough, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Report sent to call center — day 42, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-06-28
Call successfulParticipant prefers to complete VAERS report online
- 2022-08-15
- 2022-11-15
- 2023-05-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Pfizer-BioNTech | |
| 2 | 2021-05-03 | Pfizer-BioNTech | |
| 3 | 2022-05-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — day 21, dose 3
Symptoms: Increased nausea and vomiting.
Release 12 — day 35, dose 3
Symptoms: Lots of congestion, sneezing, mild cough.
Release 12 — day 42, dose 3
Symptoms: Mild fever, bad cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release